Clinical supply chain management
End-to-end clinical supply chain management from pre-IND planning through active trial oversight, domestic and global. We manage the complexity so your team can focus on the science.
How we help
From single-site domestic studies to multi-region global trials, including emerging clinical regions with complex cold-chain infrastructure.
Gap analysis, IRT specification, vendor selection, forecasting architecture, TMF planning
IRT build oversight, demand forecasting, site readiness, excursion management
Multi-region coordination, cross-study forecasting, vendor performance, regulatory documentation
Bispecifics, multiTAA, autologous & allogeneic cell therapies, gene therapies
Proven experience
An immuno-oncology company developing multiTAA T cell therapies needed an embedded clinical supply chain manager to run the full vein-to-vei...
A cell therapy company preparing for a Phase 3 study needed a complete clinical supply chain strategy. During the engagement, we identified ...
Free assessment
Answer a few questions about your study and we'll show you where the risks are, what to prioritize, and how to close the gaps.
Take the assessmentAbout Aseda
Our team brings deep experience across biologics, bispecifics, multiTAA platforms, and cell therapies, managing supply chains from pre-IND planning through global Phase 3 trials.
Learn moreBiologics
All temperature ranges
Cell therapies
Autologous & allogeneic
Bispecifics
Multi-component logistics
Global trials
Including emerging regions
Whether you're planning ahead or need support now, we'll find the right approach for your supply chain.